Lime is rolling out a Cycle to Work scheme that allows employees to pay for an annual e-bike subscription through salary sacrifice, reducing costs by up to 47 per cent. The reduction
More
The 2027 Lamborghini Temerario has received a series of software updates designed to sharpen its character without altering its exterior or interior layout. Paolo Rachetti, product line director for the Temerario, confirmed
More
Saudi Arabia is sending more crude through the Strait of Hormuz just as the waterway grows more dangerous, according to new analysis from Kpler. A drone strike on the kingdom’s East-West pipeline
More
John Healey is set to place Royal Navy upgrades at the heart of his keynote Labour Party conference speech, promising a bold industrial revival for Britain. The Chancellor will use his address
More
Ask around the City which commodity will shape the next decade and you will hear oil, copper, perhaps lithium. Nobody says phosphate rock. It has no ticker worth watching, no lobby to
More
Digital bank Monzo is in early discussions with Brazilian fintech powerhouse Nubank over a potential acquisition that could reach a valuation of between £8bn and £10bn. The UK fintech has been approached
More
Treasury yields surged sharply on Wednesday, raising alarm about the broader impact on consumers, borrowing costs, and overall economic momentum across the United States. Rates along the curve hit levels not seen
More
The Conservative Party has unveiled plans to restrict how benefit claimants spend their welfare payments using a dedicated spending card. Under the proposed crackdown, unemployed people on benefits would see their payments
More
Chancellor John Healey and Prime Minister Andy Burnham could raise £26bn through sweeping reforms to capital gains taxes and national insurance contributions, according to a new academic proposal. Researchers at the Centre
More
Accenture (ACN) is among a handful of stocks drawing significant investor attention as markets prepare to open for the new trading week. Abivax (ABVX), the French biopharmaceutical company, is also on the
More